| [1] |
Bikbov B, Purcell C, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2020, 395(10225): 709-733.
|
| [2] |
Kalantar-Zadeh K, Jafar TH, Nitsch D, et al. Chronic kidney disease [J]. Lancet, 2021, 398(10302): 786-802.
|
| [3] |
Berger I, Wu S, Masson P, et al. Cognition in chronic kidney disease: a systematic review and meta-analysis [J]. BMC Med, 2016, 14(1): 206.
|
| [4] |
Seliger SL, Wendell CR, Waldstein SR, et al. Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging [J]. Am J Nephrol, 2015, 41(4-5): 305-312.
|
| [5] |
Etgen T, Chonchol M, Förstl H, et al. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis [J]. Am J Nephrol, 2012, 35(5): 474-482.
|
| [6] |
Viggiano D, Wagner CA, Martino G, et al. Mechanisms of cognitive dysfunction in CKD [J]. Nat Rev Nephrol, 2020, 16(8): 452-469.
|
| [7] |
Raphael KL, Wei G, Greene T, et al. Cognitive function and the risk of death in chronic kidney disease [J]. Am J Nephrol, 2012, 35(1): 49-57.
|
| [8] |
Griva K, Stygall J, Hankins M, et al. Cognitive impairment and 7-year mortality in dialysis patients [J]. Am J Kidney Dis, 2010, 56(4): 693-703.
|
| [9] |
van ZA, Wong G, Ruospo M, et al. Associations of cognitive function and education level with all-cause mortality in adults on hemodialysis: findings from the COGNITIVE-HD Study [J]. Am J Kidney Dis, 2019, 74(4): 452-462.
|
| [10] |
Marcos G, Santabárbara J, Lopez-Anton R, et al. Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen′s criteria [J]. Acta Psychiatr Scand, 2016, 133(5): 378-385.
|
| [11] |
Armstrong A. Risk factors for Alzheimer′s disease [J]. Folia Neuropathol, 2019, 57(2): 87-105.
|
| [12] |
Lipnicki DM, Crawford J, Kochan NA, et al. Risk factors for mild cognitive impairment, dementia and mortality: the Sydney memory and ageing study [J]. J Am Med Dir Assoc, 2017, 18(5): 388-395.
|
| [13] |
Tamura MK, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies [J]. Kidney Int, 2011, 79(1): 14-22.
|
| [14] |
Kuo YT, Li CY, Sung JM, et al. Risk of dementia in patients with end-stage renal disease under maintenance dialysis-a nationwide population-based study with consideration of competing risk of mortality [J]. Alzheimers Res Ther, 2019, 11(1): 1-12.
|
| [15] |
Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention [J]. Am J Kidney Dis, 2019, 74(6): 782-790.
|
| [16] |
Lin YT, Wu PH, Liang SS, et al. Protein-bound uremic toxins are associated with cognitive function among patients undergoing maintenance hemodialysis [J]. Sci Rep, 2019, 9(1): 20388.
|
| [17] |
Ravid JD, Kamel MH, Chitalia VC. Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease [J]. Nat Rev Nephrol, 2021, 17(6): 402-416.
|
| [18] |
Walker JA, Richards S, Belghasem ME, et al. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease [J]. Kidney Int, 2020, 97(3): 538-550.
|
| [19] |
Dou L, Sallée M, Cerini C, et al. The cardiovascular effect of the uremic solute indole-3 acetic acid [J]. J Am Soc Nephrol, 2015, 26(4): 876-887.
|
| [20] |
Adesso S, Paterniti I, Cuzzocrea S, et al. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells [J]. J Clin Med, 2018, 7(10): 365.
|
| [21] |
Tsuruya K, Yoshida H. Brain atrophy and cognitive impairment in chronic kidney disease [J]. Contrib Nephrol, 2018, 196: 27-36.
|
| [22] |
Lee JH, Yoon YM, Lee SH. TUDCA-treated mesenchymal stem cells protect against ER stress in the hippocampus of a murine chronic kidney disease model [J]. Int J Mol Sci, 2019, 20(3): 613.
|
| [23] |
Miller LM, Rifkin D, Lee AK, et al. Association of urine biomarkers of kidney tubule injury and dysfunction with frailty index and cognitive function in persons with CKD in SPRINT [J]. Am J Kidney Dis, 2021, 78(4): 530-540.
|
| [24] |
Lidgard B, Bansal N, Zelnick LR, et al. Association of proximal tubular secretory clearance with long-term decline in cognitive function [J]. J Am Soc Nephrol, 2022, 33(7): 1391-1401.
|
| [25] |
Cunningham C, Hennessy E. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research [J]. Alzheimers Res Ther, 2015, 7(1): 33.
|
| [26] |
Tamura MK, Tam K, Vittinghoff E, et al. Inflammatory markers and risk for cognitive decline in chronic kidney disease: the CRIC study [J]. Kidney Int Rep, 2017, 2(2): 192-200.
|
| [27] |
Meng C, Zhang JC, Shi RL, et al. Inhibition of interleukin-6 abolishes the promoting effects of pair housing on post-stroke neurogenesis [J]. Neuroscience, 2015, 307: 160-170.
|
| [28] |
Huang C, Irwin MG, Wong GTC, et al. Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model [J]. J Neuroinflammation, 2018, 15(1): 147.
|
| [29] |
Sedaghat S, Vernooij MW, Loehrer E, et al. Kidney function and cerebral blood flow: the rotterdam study [J]. J Am Soc Nephrol, 2016, 27(3): 715-721.
|
| [30] |
Miyazawa H, Ookawara S, Ito K, et al. Association of cerebral oxygenation with estimated glomerular filtration rate and cognitive function in chronic kidney disease patients without dialysis therapy [J]. PLoS One, 2018, 13(6): e0199366.
|
| [31] |
Kovarova L, Valerianova A, Kmentova T, et al. Low cerebral oxygenation is associated with cognitive impairment in chronic hemodialysis patients [J]. Nephron, 2018, 139(2): 113-119.
|
| [32] |
Findlay MD, Dawson J, Dickie DA, et al. Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients [J]. J Am Soc Nephrol, 2019, 30(1): 147-158.
|
| [33] |
Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter [J]. J Am Soc Nephrol, 2015, 26(4): 957-965.
|
| [34] |
Aggarwal HK, Jain D, Bhavikatti A. Cognitive dysfunction in patients with chronic kidney disease [J]. Saudi J Kidney Dis Transpl, 2020, 31(4): 796-804.
|
| [35] |
Lourida I, Thompson-Coon J, Dickens CM, et al. Parathyroid hormone, cognitive function and dementia: a systematic review [J]. PLoS One, 2015, 10(5): e0127574.
|
| [36] |
Kuriyama N, Ozaki E, Mizuno T, et al. Association between α-Klotho and deep white matter lesions in the brain: a pilot case control study using brain MRI [J]. J Alzheimers Dis, 2018, 61(1): 145-155.
|
| [37] |
McGrath ER, Himali JJ, Levy D, et al. Circulating fibroblast growth factor 23 levels and incident dementia: the Framingham heart study [J]. PLoS One, 2019, 14(3): e0213321.
|
| [38] |
Mayne PE, Burne THJ. Vitamin D in synaptic plasticity, cognitive function, and neuropsychiatric illness [J]. Trends Neurosci, 2019, 42(4): 293-306.
|
| [39] |
Mazumder MK, Paul R, Bhattacharya P, et al. Neurological sequel of chronic kidney disease: from diminished acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain [J]. Sci Rep, 2019, 9(1): 3097.
|
| [40] |
Kim JW, Ha GY, Jung YW. Chronic renal failure induces cell death in rat hippocampal CA1 via upregulation of αCaMKII/NR2A synaptic complex and phosphorylated GluR1-containing AMPA receptor cascades [J]. Kidney Res Clin Pract, 2014, 33(3): 132-138.
|
| [41] |
Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β [J]. Sci Transl Med, 2012, 4(147): 147ra111.
|
| [42] |
Heo CM, Lee DA, Park KM, et al. Glymphatic system dysfunction in patients with early chronic kidney disease [J]. Front Neurol, 2022, 13: 976089.
|
| [43] |
Heo CM, Lee WH, Park BS, et al. Glymphatic dysfunction in patients with end-stage renal disease [J]. Front Neurol, 2022, 12: 809438.
|
| [44] |
Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders [J]. Lancet Neurol, 2018, 17(11): 1016-1024.
|
| [45] |
Jiang Q, Zhang L, Ding G, et al. Impairment of the glymphatic system after diabetes [J]. J Cereb Blood Flow Metab, 2017, 37(4): 1326-1337.
|
| [46] |
Mortensen KN, Sanggaard S, Mestre H, et al. Impaired glymphatic transport in spontaneously hypertensive rats [J]. J Neurosci, 2019, 39(32): 6365-6377.
|
| [47] |
Verbitsky M, Kogon AJ, Matheson M, et al. Genomic disorders and neurocognitive impairment in pediatric CKD [J]. J Am Soc Nephrol, 2017, 28(8): 2303-2309.
|
| [48] |
Mengel-From J, Soerensen M, Nygaard M, et al. Genetic variants in klotho associate with cognitive function in the oldest old group [J]. J Gerontol A Biol Sci Med Sci, 2016, 71(9): 1151-1159.
|
| [49] |
Joshee P, Wood AG, Wood ER, et al. Meta-analysis of cognitive functioning in patients following kidney transplantation [J]. Nephrol Dial Transplant, 2018, 33(7): 1268-1277.
|
| [50] |
Lepping RJ, Montgomery RN, Sharma P, et al. Normalization of cerebral blood flow, neurochemicals, and white matter integrity after kidney transplantation [J]. J Am Soc Nephrol, 2021, 32(1): 177-187.
|
| [51] |
McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function [J]. Neurosci Biobehav Rev, 2009, 33(3): 355-366.
|
| [52] |
Skardelly M, Glien A, Groba C, et al. The influence of immunosuppressive drugs on neural stem/progenitor cell fate in vitro [J]. Exp Cell Res, 2013, 319(20): 3170-3181.
|
| [53] |
Kashgary A, Khojah A, Bamalan B, et al. Effect of hemodiafiltration versus hemodialysis on cognitive function among patients with end-stage renal disease: a multicenter study [J]. Cureus, 2021, 13(11): e19719.
|
| [54] |
Lin YT, Wu PH, Kuo MC, et al. Comparison of dementia risk between end stage renal disease patients with hemodialysis and peritoneal dialysis-a population based study [J]. Sci Rep, 2015, 5: 8224.
|